Increased S100A8 expression in bone marrow plasma by monocytic cells from acute myeloid leukemia patients

Hematol Oncol. 2020 Feb;38(1):114-118. doi: 10.1002/hon.2707. Epub 2020 Jan 6.

Julie Mondet^{1

2}, David Laurin^{1

3}, Caroline Lo Presti¹, Marie-Christine Jacob⁴, Mathieu Meunier^{1

5}, Emmanuelle Giraudon⁶, Christine Lefebvre⁷, Sylvie Berthier⁸, Anne Mc Leer^{1

2}, Sophie Park^{1

5}, Pascal Mossuz^{1

6}

¹ Institute for Advanced Biosciences, University Grenoble Alpes /INSERM U1209/CNRS 5309, Grenoble, France.
² Molecular Pathology Laboratory, Centre Hospitalier Grenoble Alpes, Grenoble, France.
³ Etablissement Français du Sang, La Tronche, France.
⁴ Immunology Laboratory, Centre Hospitalier Grenoble Alpes, Grenoble, France.
⁵ Department of Clinical Hematology, Centre Hospitalier Grenoble Alpes, Grenoble, France.
⁶ Department of Biological Hematology, Centre Hospitalier Grenoble Alpes, Grenoble, France.
⁷ Oncohematology Laboratory, Centre Hospitalier Grenoble Alpes, Grenoble, France.
⁸ Flow Cytometry Platform, Centre Hospitalier Grenoble Alpes, Grenoble, France.

No abstract available

Keywords: DAMP; S100A8; acute myeloid leukemia; bone marrow plasma; extra cellular microenvironment.

Publication types